<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04213443</url>
  </required_header>
  <id_info>
    <org_study_id>0275-19-RMB</org_study_id>
    <nct_id>NCT04213443</nct_id>
  </id_info>
  <brief_title>Fetal Growth Pattern in Short Stature Women</brief_title>
  <official_title>Fetal Growth Pattern in Short Stature Women as a Model for True Intrauterine Growth Restriction Prediction.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Women of short stature tend to be classified regarding fetal growth by the same criteria as
      women of normal and tall stature. The objective of the following study is to evaluate fetal
      growth patterns parallel to women`s height and try to make conclusions regarding possible
      definitions of subjective Intra-uterine growth restriction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on a patient registry, women of short stature tend to be classified regarding fetal
      growth by the same criteria as women of normal and tall stature. The objective of the
      following study is to evaluate fetal growth patterns parallel to women`s height and try to
      make conclusions regarding possible definitions of subjective Intra-uterine growth
      restriction.

      Informed consent is not required due to the retrospective nature of the study. Patient
      information including medical, obstetric and general background will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated fetal weight changes.</measure>
    <time_frame>Up to 1 year from admission.</time_frame>
    <description>Changes in estimated fetal weight during pregnancy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Intrauterine Growth Restriction</condition>
  <arm_group>
    <arm_group_label>Women of short stature</arm_group_label>
    <description>Women that are under 1.6 meters.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Analysis of a patient registry</intervention_name>
    <description>Analysis of a patient registry.</description>
    <arm_group_label>Women of short stature</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women of short stature under 1.6 meters.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women under 1.6 meters of height.

          -  Singleton pregnancy.

          -  Low risk pregnancy.

          -  Accurate dating.

        Exclusion Criteria:

          -  Women over 1.6 meters of height.

          -  Multiple pregnancy.

          -  High risk pregnancy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy Lauterbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam healthcare campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roy Lauterbach, MD</last_name>
    <phone>+972529432416</phone>
    <email>r_lauterbach@rmc.gov.il</email>
  </overall_contact>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 26, 2019</study_first_submitted>
  <study_first_submitted_qc>December 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2019</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

